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 Chapter 11 
 HT29 Cell Line 
 Daniel  Martínez-Maqueda ,  Beatriz  Miralles , and  Isidra  Recio 
 Abstract  The human colon adenocarcinoma cell line HT29, is not only used to 
study the biology of human colon cancers, but it is receiving special interest in 
 studies focused on food digestion and bioavailability due to the ability to express 
characteristics of mature intestinal cells. In the differentiated phenotype, they are 
able to form a monolayer with tight junctions between cells and a typical apical 
brush border. In addition, these differentiated cells express brush-border- associated 
hydrolases typical of the small intestine although the enzymatic activity is lower 
than that found in vivo. Although they represent a valuable model due to their simi-
larities with enterocytes of the small intestine, their limitations and the relevance to 
the in vivo situation are also considered in this chapter. The application of this cell 
line to transport studies of drugs and food compounds is illustrated, especially 
when the effect of the mucus layer is considered or used as co-culture in combina-
tion with Caco-2 cells. They have also been frequently used to study the intestinal 
immune response to bacterial infection, and microorganism survival, adhesion or 
invasion. Finally, the use of these cells to evaluate the effect of several food com-
pounds and mucin secretion is summarized. 
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11.1  Origin 
 The human colon adenocarcinoma cell line HT29 was isolated from a primary tumor 
of a 44 years old Caucasian female in 1964 by Fogh and Trempe ( 1975 ). Since then, 
many cell lines have been derived from human colon cancers. Initially, this cell line 
was used to study different aspects of the biology of human cancers. However, these 
cells have attracted attention due to the fact they were able to express characteristics 
of mature intestinal cells, such as enterocytes or mucus producing cells. 
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11.2  Features and Mechanisms 
 These cells have shown a high rate of glucose consumption and therefore, they 
require high glucose concentration in the medium. Under these standard growth 
conditions, i.e., in the presence of 25 mM glucose and 10 % serum, these cells 
display an undifferentiated phenotype; they grow as a multilayer of unpolarised 
undifferentiated cells, and functionally they do not express any typical characteris-
tics of intestinal epithelial cells, and they express low amounts of hydrolases. Since 
the discovery that the replacement of glucose by galactose in the culture medium 
induced a reversible enterocytic differentiation (Pinto et al.  1982 ), HT29 cells have 
become a unique model for studying the molecular mechanisms of intestinal cell 
differentiation. When these cells are grown under appropriate culture conditions or 
after treatment with different inducers, like butyrate (Augeron and Laboisse  1984 ) 
or acid (Fitzgerald et al.  1997 ), they can be modulated to express different pathways 
of enterocyte differentiation. For this reason, HT29 is considered a pluripotent 
intestinal cell line which can be used for the study of the structural and molecular 
events involved in cell differentiation. 
 The polarised phenotype is characterised morphologically, physiologically and by 
biochemical markers. The differentiation is growth-related, starting after confl uence 
(after 15 days of growth), and the cells form a monolayer with tight junctions between 
cells and a typical apical brush border. The brush border of these differentiated cells 
contains proteins which are normally present in the intestinal microvilli, such as villin. 
In addition, these differentiated cells express brush border-associated hydrolases typi-
cal for the small intestine, have brush border microvilli although the enzyme activities 
is much lower than that of the normal intestine, and do not express lactase. The maxi-
mum enzyme activities, such as sucrose-isomaltase, aminopeptidase N, dipeptidyl-
peptidase-IV and alkaline phosphatase, are reached after 30 days in culture. Under 
these conditions, p.e. growth in glucose-free medium, cell differentiation is very 
similar to that observed in Caco-2 cells but in HT29 the time course of the differentia-
tion process is longer (30 days vs. 15–20 days in Caco-2); the levels of enzymatic 
activities are lower than in Caco-2; lactase is absent; and only 40–50 % of HT29 cells 
express sucrose-isomaltase (Zweibaum  1986 ; Zweibaum et al.  2011 ). However, one 
of the main differences between this cell line and Caco-2 is that HT29 cells can 
produce mucin at a relatively high level (Huet et al.  1987 ; Maoret et al.  1989 ). Stepwise 
adaptation of exponentially growing HT29 cells to increasing concentrations of meth-
otrexate (MTX) (up to 10 −5 mol) resulted in their transformation into mucus-secreting 
differentiated cells (Lesuffl eur et al.  1990 ). As occurs under other metabolic stress 
conditions like glucose- deprivation, after a high rate of mortality, the resistance to 
MTX is associated with the cells possessing this stable differentiated mucus-secreting 
phenotype. Interestingly, cells adapted to low-dose MTX consist of a double popula-
tion of columnar absorptive and mucus-secreting cells and, at a higher dose, cells are 
almost exclusively of mucus-secreting phenotype. This mucus-secreting phenotype 
has been used in the transport studies of different compounds, to study the mucus- 
inducing properties of different food compounds or in studies regarding microorganisms 
adhesion and survival (see Sect.  11.6 ). 
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 The factors secreted from cells in culture medium include metabolites, cytokines, 
growth factors, etc., which are known to promote cell survival. Recently, the soluble 
factors secreted by HT29 and other tumor cells in basal conditions and after gamma 
radiation have been reported. HT29 secreted pro-infl ammatory cytokines, such as, 
tumor necrosis factor (TNF) α and interleukins (IL) 1β and IL 6; growth factors such 
as platelet-derived growth factor AA and transforming growth factors (TGF) α and 
β; chemokines such as fractalkine, IL-8, monocyte chemoattractant protein-1 and 
interferon-γ-induced protein 10; pro-angiogenic factors such as IL-15 and vascular 
endothelial growth factor; and immune-modulatory cytokines such as granulocyte 
colony-stimulating factor, granulocyte macrophage colony-stimulating factor and 
IL-3. It was suggested, based on previous reports on biopsy samples, that in vivo, 
a similar cytokine secretion profi le can be observed (Desai et al.  2013 ). 
11.3  Stability, Consistency and Reproducibility 
 Many tumor-derived cells have been reported to show lack of culture stability and 
reproducibility based on the existence of irregular growth and non-specifi c genetic 
alterations (Lipps et al.  2013 ). To minimize these handicaps, the establishment of 
large cell banks is recommended to allow disposing cells at early and similar 
 passages. On the contrary, the consistency of the assumed cell properties should be 
verifi ed for highly different passages. For instance, Chen et al. ( 1987 ) proved that 
karyotypes were comparable for HT29 cells along more than 100 passages, which 
represents valuable data in the assessment of the cell line evolution. Likewise, derived 
cells adapted by specifi c treatments must be evaluated under different culture condi-
tions as time and presence/absence of responsible agent(s). Lesuffl eur et al. ( 1990 ) 
tested the irreversibility of the differentiation of MTX adapted cells by the compari-
son of the growth curve for several passages. No signifi cant differences were observed 
for both 10 −7 and 10 −6 M MTX-derived cell lines between cells cultured with drug-
enriched media and drug-free media. The stability of other differentiation character-
istics was also confi rmed for MTX-free cells compared with equivalent MTX-treated 
cells as well as themselves along several passages before. 
11.4  Relevance to Human In Vivo Situation 
 As in other cancer-derived cell line models, signifi cant differences in the gene 
expression of transporters and metabolic enzymes from the normal human intestinal 
cells can affect the suitability of the model in refl ecting the in vivo permeability 
(Langerholc et al.  2011 ). Similar protein expression was found in HT29 cells and the 
corresponding intestinal scrapings, of which some appear to be characteristic to 
human intestinal epithelium in vivo (Lenaerts et al.  2007 ). Nevertheless, several pro-
teins, including transporters, were over- or underexpressed. Bourgine et al. ( 2012 ) 
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compared the expression of 377 genes in HT29 and other intestinal cell lines that 
are used as in vitro models of the epithelium with the corresponding tissue biopsy. 
The results showed that differentiated HT29 cells and human colonic tissues do not 
appear to be signifi cantly different. 
 The use of HT29 as in vitro model of intestinal cells has some advantages and 
limitations that have been summarized by Zweibaum et al. ( 2011 ). This cell line in 
its differentiated phenotype is similar to small intestine enterocytes with respect 
their structure, and the presence of brush border-associated hydrolases and the time 
course of the differentiation process which is also comparable to that found in the 
small intestine. In addition, the amount of villin expressed in differentiated HT29 
cells is close to the value observed for normal freshly prepared colonocytes. 
However, these cells also have some limitations, because (1) they are malignant 
cells with a high rate of glucose consumption and an impairment of the metabolism 
of glucose; (2) although they mimic some characteristics of small intestine entero-
cytes, they are colonic cells; (3) they cannot be compared with enterocytes from 
normal colon since they express brush border-associated hydrolases; (4) but they 
cannot be compared with absorptive enterocytes because not all hydrolases are pres-
ent (e.g. lactase and maltase-glucoamylase are absent) and the ion transport proper-
ties are different. It has been postulated that these cells are close to human fetal 
colonic cells because of the type of hydrolases present and the intracellular concen-
tration of glycogen accumulated (Hekmati et al.  1990 ). 
 Regarding the expression of cell surface receptors, it has been reported that dif-
ferentiated HT29 cells express several receptors for peptides, such as vasoactive 
intestinal peptide, or insulin but also for non-peptide substances. In general, the 
receptors found in this cell line have their equivalent in normal intestinal cells, 
except for the receptor to neurotensin, which has been characterised in HT29 cells 
(Kitabgi et al.  1980 ), but it is not detectable in normal human colonic epithelium. 
On the contrary, receptors for peptide YY or neuropeptide Y which are well charac-
terised in normal small intestine epithelial cells have not been reported in HT29. It 
has to be taken into account that these receptors are located at the small intestine and 
that HT29 are of colonic origin. It is also remarkable that when using cell cultures, 
the expression of a particular receptor may depend on the degree of cell differentia-
tion and the growing conditions. Recently, the presence of opioid, serotonin, mus-
carinic, PPARβ/δ receptors has been reported in this cell line (Zoghbi et al.  2006 ; 
Ataee et al.  2010 ; Belo et al.  2011 ; Foreman et al.  2011 ). Information on the studies 
on receptors carried out in this cell line can be found at Zweibaum et al. ( 2011 ). 
11.5  General Protocol for HT29-MTX Cells 
11.5.1  Cell Maintenance Protocol 
 HT29-MTX cells are cultured using DMEM medium with high glucose (25 mM), 
without sodium pyruvate, but with GlutaMAX ® (Gibco, Paisley, UK), 10 % of heat- 
inactivated fetal bovine serum and penicillin/streptomycin (100 units/mL of penicillin 
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and 100 μg/mL of streptomycin) in a humidifi ed incubator with 5 % CO 2 atmosphere 
at 37 °C. Culture medium is changed every 2 days from the second day after seed-
ing, and cells are harvested in the logarithmic phase of growth after reaching 
80–90 % confl uency by 0.05 % trypsin/EDTA. Cells are seeded at 2.4 × 10 4 cells 
per cm 2 in 75 cm 2 culture fl asks. In these conditions, cells would be confl uent at 
day 6–7 of culture. 
11.5.2  Experimental Protocol for Test Compounds 
11.5.2.1  Study of the Mucin-Stimulating Activity 
 Cells are seeded in 12-well plates at a density of 5 × 10 5 cells per well and experi-
ments are performed 21 days after confl uency to ensure that the proportion of cells 
differentiated that express mucus reaches their maximum (Lesuffl eur et al.  1993 ). 
Culture media is changed every 2 days until 24 h prior to the experiment, when 
culture media is replaced by serum- and antibiotic-free media (DMEM GlutaMAX ® ) 
to minimize any extraneous interference. On the day of the experiment, cells are 
rinsed twice with PBS and treated with tested compounds dissolved in serum- and 
antibiotic-free medium for different incubation times at 37 °C in a 5 % CO 2 humidi-
fi ed atmosphere. After treatment, cell supernatants are collected for the determina-
tion of mucins, and adhered cells are lysed to obtain the total RNA according to the 
RNA isolation kit instructions. Mucin secretion is determined in cell supernatants 
by applying an enzyme-linked lectin assay, based on the strong binding between 
wheat germ agglutinin and goblet cell mucins (Campo et al.  1988 ). Standard curves 
prepared with porcine mucin are employed, and mucin gene expression is evaluated 
after isolating and reverse-transcribing the RNA from cell lysates. A quantitative 
PCR assay is performed with specifi c primers for MUC5AC, the HT29-MTX major 
secreted mucin gene (Martínez-Maqueda et al.  2013a ). Cells are employed between 
passages 12 and 24 without remarkable basal differences. 
11.5.2.2  Evaluation of Transepithelial Absorption by Transwell ® Inserts 
 Transwell ® inserts provides a reliable model once the integrity of the cell monolayer 
is verifi ed. HT29-MTX cells are seeded in 12-well Transwell ® inserts at a density of 
5 × 10 5 cells per well and medium is changed every 2 days. Cells are cultured for at 
least 21 days to ensure a suitable cell differentiation. Prior to the experiment, the 
integrity of the cell monolayers is verifi ed by measuring the transepithelial electrical 
resistance (TEER) with a cell electrical resistance system. Only monolayers with 
initial TEER values above 200 Ω cm −2 must be used. On the day of the experiment, 
cells are rinsed with Hanks’ balanced salt solution (HBSS) and test compounds are 
dissolved in culture medium, which are added to the apical side of the cell layer 
(HBSS to the basolateral chamber). According to Foltz et al. ( 2008 ), cells are main-
tained at 37 °C in a 5 % CO 2 humidifi ed atmosphere. Transport assay is initiated by 
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adding 0.5 mL of transport medium, containing compounds of interest to the apical 
compartment. Samples (100 μL) are taken from the basolateral compartment and 
replaced by transport medium. After the end of the experiment, TEER measurement 
is repeated and permeability values are only calculated from experiments in which 
the second TEER value is at least 75 % of the initial TEER value. Fluorescein fl ux 
can be measured as a second parameter of monolayer integrity. Monolayers are 
deemed intact when TEER values were above 200 Ω cm −2 , and the permeability 
coeffi cients of the paracellular transport marker fl uorescein is less than 
1 × 10 −6 cm s −1 . Apical and basolateral solutions can be collected and analyzed by 
RP-HPLC–MS/MS to evaluate the permeability, including permeability coeffi -
cients as indicated by Quirós et al. ( 2008 ) and Contreras et al. ( 2012 ), and degradation 
of tested compounds. 
11.6  Experimental Read Out 
11.6.1  Functionality Studies 
 HT29 cells have been widely employed to assess the potential anticancer effect of 
different food compounds, and their gastrointestinal digests, on the basis of the 
carcinoma origin of this cell line. An illustrative example is found in the study of the 
antiproliferative activity of the in vitro gastrointestinal digest of sea cucumber wall 
(Pérez-Vega et al.  2013 ). Another representative study is found in the assessment of 
the cytotoxic activity of different extracts from “Racimo” tomato variety and simu-
lated digests against HT29 cell growth, including also the evaluation of the selectiv-
ity of the toxic effect against cancer cells (Guil-Guerrero et al.  2011 ). Other activities 
have been widely studied on HT29 cells or derived lines, such as immunomodula-
tory, antioxidant or barrier protective properties. For instance, milk and soy fer-
ments with different strains of lactic acid bacteria (LAB) were evaluated on human 
intestinal epithelial cells, including HT29 cells, to test their immunomodulatory 
activity (Wagar et al.  2009 ). The study was carried out on cells treated with TNF-α 
and the production of IL-8 was evaluated in the cell supernatant by a commercial 
enzyme-linked immunosorbent assay. Another investigation focused on the study of 
the immunomodulatory activity of cereal β-glucan preparations on both HT29 and 
Caco-2 cells (Rieder et al.  2011 ). In vitro data of antioxidative activity for food 
compounds is often presented together with genotoxic tests performed with HT29 
cells. Among others, the comet assay has become one of the standard methods for 
assessing DNA integrity (Collins  2004 ). Ferguson et al. ( 2005 ) demonstrated both 
in vitro antioxidant activity and antigenotoxic effect in HT29 cells by using a comet 
assay for two hydroxycinnamic acids with an important percentage in certain plant 
foods, as spinach or cereals. Interestingly, the protection of resveratrol and querce-
tin against exogenous pro-oxidative damage was determined in HT29 cells with 
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induced oxidative stress by addition of fatty acid hydroperoxides (Kaindl et al. 
 2008 ). HT29-derived cell lines constitute a valuable tool related to the strengthening 
of the intestinal mucus barrier to study the mucin-stimulating activity of food com-
pounds. The protocol described above has been recently applied to asses the mucin-
stimulating effect of certain milk protein hydrolysates and derived peptides 
(Martínez-Maqueda et al.  2012 ,  2013a ,  b ). HT29-MTX cells and an analogous 
experimental design was also implemented to evaluate the regulation of the mucin 
production by the β-casomorphin-7, a μ-opioid peptide derived from bovine milk 
(Zoghbi et al.  2006 ), or by a yoghurt peptide pool (Plaisancié et al.  2013 ). Other 
HT29 derived cell lines have been employed due to their capability to form a mucus-
layer, e.g. HT29/B6 cells differentiated in a glucose-free culture (Kreusel et al. 
 1991 ). Hering et al. ( 2011 ) evaluated the expression of tight junction proteins and 
the related intestinal barrier-protection in HT29/B6 cells, under the effect of TGF-β, 
a whey protein component. Likewise, monoterpene  d -limonene, naturally occurring 
in the rind of citrus fruit, showed a signifi cant increase on the transepithelial resis-
tance in HT29/B6 cells (D’Alessio et al.  2013 ). 
11.6.2  Transport Studies 
 The HT29 cell line is not a particularly suitable model for transport studies, but it 
has been used for comparison with other lines or as co-culture. Monolayers of 
HT29-MTX cells have been previously used as a permeability model, for example 
for studying the effect of mucus on the permeation of drugs. However, in most 
cases, transport studies and permeation enhancement studies are performed with 
co-cultures of Caco-2 and HT29-MTX as an accurate model to take into account the 
mucus layer (Yuan et al.  2013 ). 
 It has been reported that casein phosphopeptides (CPPs) form aggregated 
 complexes with calcium phosphate and induce Ca 2+ infl ux into HT29 cells that have 
been shown to be differentiated in culture. Taking into account that upon differentia-
tion HT29 cells elicit a transient rise in Ca 2+ , this model is being used to explore the 
molecular mechanism by which CPPs elicit their biological activity (Gravaghi et al. 
 2007 ). Similarly, the HT29 cell line is a useful model to study key players involved 
in intestinal iron absorption because it endogenously expresses a number of genes 
known to be involved in iron transport in the intestine. Using this model, it has been 
suggested that the hemochromatosis protein HFE can have multiple roles in main-
taining iron homeostasis depending on the availability of other proteins (Davies and 
Enns  2004 ). 
 HT29 cells have also been applied to the study of the receptor and internalization 
transporter of toxins. As for the  Clostridium botulinum C16S toxin, it was reported 
that the receptor on the HT29 cell surface targeted is an O-linked sugar chain of 
mucin-like glycoproteins (Nishikawa et al.  2004 ). 
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11.6.3  Microorganisms Survival, Adhesion or Invasion 
 The HT29 cells represent a well characterised model to study the intestinal epithelial 
response to bacterial infection. This cell line expresses the features of enterocytes 
and is useful for attachment and mechanistic studies. Mucin secretion by these cells 
is of importance because the mucus layer has been suggested to play a role in modu-
lating the adhesion of live organisms to the epithelial surface as well as bacterial 
components such as LPS (Otte and Podolsky  2004 ). 
 The mechanisms underlying enteropathogenesis are one of the most important 
applications of this cell model. Studies on attachment, adherence and/or internaliza-
tion of several pathogens such as  Entamoeba histolytica ,  Salmonella enteriditis , 
 Escherichia coli ,  Clostridium diffi cile ,  Campylobacter jejuni ,  Clostridium butyri-
cum or  Shigella disenteriae , in some cases with food components intended to limit 
their access to cells have been reported. For example, in the study of Nickerson and 
McDonald ( 2012 ) it was shown that exposure to maltodextrin induced type I pilus 
expression, which was required for enhanced biofi lm formation by  E. coli in Crohn’s 
disease patients. Comparison of the results with those found in the HT29 cell model 
was used to suggest a novel mechanism of epithelial cell adhesion that can contribute 
to disease susceptibility. 
 Studies intended to evaluate the benefi cial role of probiotics in the human host 
are another application of the cell model. For the study of probiotic adhesion, the 
HT29 cell line and some HT29-derived lines have been used to study the molecular 
mechanisms underpinning host-microbe interactions or the enteric adaptation fea-
tures of  Bifi dobacterium strains, sometimes in the presence of food components as 
milk oligosaccharides (Kavanaugh et al.  2013 ). Probiotic delivery systems by coat-
ing biopolymers are also evaluated by using colonic epithelial models that are 
intended to mimic the colonic mucosa. The intestinal mucus offers numerous eco-
logical advantages for both resident microbiotic bacteria and some pathogenic 
 bacteria present within the lumen and in the intestinal epithelium. It can provide 
nutrients for bacterial growth, thus promoting intestinal colonization by the adher-
ing bacteria which have the ability to survive and multiply in the outer regions of 
the mucus layer (Liévin-Le Moal and Servin  2006 ). 
 In response to enteropathogens infection, the intestinal epithelium releases the 
chemokine IL-8 and other pro-infl ammatory molecules that provoke an acute 
infl ammatory response. For the protection against enteropathogens infections, the 
possibility of using food supplements containing probiotic bacteria is increasingly 
considered. Selected strains have shown to be able to survive under gastrointestinal 
challenges, while they were shown to adhere to human epithelial intestinal cell 
monolayers (Caco-2 and HT29), thereby preventing the establishment of enteric 
pathogens as  E. coli and  Cronobacter sakazakii (Serafi ni et al.  2013 ). Furthermore, 
many probiotic strains have been assessed for their immunomodulatory activity on 
IL-8 production by HT29 cells, protecting them from an acute infl ammatory 
response (Candela et al.  2008 ). 
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11.7  Conclusions 
 Despite several limitations of the human colon carcinoma cell lines, they are valuable 
tools to study several aspects related with food digestion and bioavailability of food 
compounds. HT29 cell line and some derived cell lines thereof are of interest to 
study food component absorption, especially when used in co-culture with other 
epithelial cell lines. Although the quantitative results can be questioned in comparison 
with those obtained in vivo, these in vitro models allow to identify modifi cations 
that the food compound may suffer during absorption and these results will help to 
perform further in vivo studies in animal or humans. The use of these human cells 
also offers a valuable opportunity to perform studies when a variance in response 
between different species is observed. For instance, the mucus secreting phenotype 
of HT29 cell line has proved to be a valuable model to screen food compounds or 
bacteria which may infl uence mucus secreting properties in the gut. Finally, it has 
provided results about the mechanisms by which microbes adhere, invade and 
signal to the host, as well as, to examine the mammalian cell response. Altogether, 
they are a complementary tool to the in vivo and ex vivo strategies to study food 
digestion and the effect of food components on the gut. 
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